Private-sector partnerships are essential to OTRADI's mission as well as the health of the Bioscience community in Oregon.
In addition to accepting fee-for service contracts, OTRADI offers grant-partnering and participates in collaborative research proposals with universities and bioscience businesses. In additions, OTRADI has launched its own research initiatives with an eye toward commercialization. OTRADI has recently instituted a fund to accelerate projects with commercial potential; OTRADI's Innovation and Commercialization Fund (OICF) is available to researchers from bioscience businesses and universities to support and promote projects with potential for future commercialization and bioscience growth in Oregon.
OICF details coming soon.
"OTRADI could provide significant economic benefit to the state by matching chemists and biologists to produce new therapeutics and intellectual property that would be owned by OHSU and the Oregon University System. Drug discovery is not easy and there are many failures along the way, but I expect the number and quality of hits coming out of OTRADI to increase as its technological capabilities grow. Just a few successes will richly reward the state." — Jeff King, Ph.D., chief operating officer of ID Biopharma Inc. and Virogenomics